Skip to main content
Premium Trial:

Request an Annual Quote

Philip Padou, David Schwartz, Ben Bulkley, John Radak, Bernd Brust, Kelli Richard

Bio-Rad reported last week that board member Philip Padou has died at the age of 72.
 
Padou joined Bio-Rad’s Board in 1980, and he was VP and CFO of Ozier Perry and Associates until his retirement in 1991.
 
David Schwartz, chairman of Bio-Rad’s board, said in a statement that Padou was “a dedicated and valuable member” of the board.
 
The company said it will begin seeking a replacement for Padou as soon as possible.
 

 
Invitrogen disclosed in an SEC filing last week that senior VP of commercial operations Ben Bulkley and finance and principal accounting officer John Radak will leave the company at the end of January.
 
Radak is taking on the role of CFO at Quidel, a developer of diagnostics for disease, at the beginning of February. 
 
Bulkley will be replaced by current GM and VP of European operations Bernd Brust. Brust will be responsible for sales strategies, customer relations, and identifying avenues for customer growth.
 
Radak will be replaced by Kelli Richard, who has served as corporate controller at Invitrogen and as VP and controller at Gateway.
 

 
Molecular detection and analysis developer ForteBio has appointed William Albright as COO, the company said last week.
 
Albright previously served as COO and senior VP of finance and operations at Xenogen (now part of Caliper), where he oversaw a $30 million IPO. At ForteBio Albright will be responsible for handling finance issues, operations and raising capital.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.